About this document
EU SMEs Expand into Chinese Market by James Dong is a document available to read on EtoBox.
IBU interviewed Boehringer Ingelheim AG, which invested $46.35 million in a joint venture in Shanghai, becoming the first biopharmaceutical manufacturer in China to use mammalian-cell culture technology. The partnership aims to meet the rising demand for high-quality biopharmaceuticals in China, while European SMEs are increasingly looking to export their innovations to the Chinese market. Haldor Topsoe also plans to expand in China, highlighting the growing opportunities for foreign trade between China and
- Author
- James Dong
- Language
- EN